ID: 130059549 | ATAC-STARR-seq lymphoblastoid active region 11226 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (82011735..82011814) | | |
ID: 130059548 | ATAC-STARR-seq lymphoblastoid active region 11225 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (82011635..82011724) | | |
ID: 130059547 | ATAC-STARR-seq lymphoblastoid silent region 7764 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (82011245..82011394) | | |
ID: 127884681 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr16:82011207-82011762 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (81977602..81978157) | | |
ID: 127884680 | NANOG hESC enhancer GRCh37_chr16:82009174-82009740 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (81975569..81976135) | | |
ID: 126862416 | MED14-independent group 3 enhancer GRCh37_chr16:82103975-82105174 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (82070370..82071569) | | |
ID: 112268169 | uncharacterized LOC112268169 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (82004456..82007894) | | |
ID: 107133503 | MT-ND6 pseudogene 28 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (82121844..82122369) | | |
ID: 107075134 | MT-CYB pseudogene 28 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (82120638..82121769, complement) | | |
ID: 106635536 | RN7SK pseudogene 176 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (81961926..81962165) | | |
ID: 105371363 | HSD17B2 antisense RNA 1 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (82044336..82066766, complement) | | |
ID: 93517 | short chain dehydrogenase/reductase family 42E, member 1 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (81988855..82011470, complement) | HSPC105 | 616164 |
ID: 5336 | phospholipase C gamma 2 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (81739041..81962685) | APLAID, FCAS3, PLC-IV, PLC-gamma-2 | 600220 |
ID: 3294 | hydroxysteroid 17-beta dehydrogenase 2 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (82035253..82098534) | EDH17B2, HSD17, SDR9C2 | 109685 |